Policy

Expanded benefits could include paying for housing among Medicaid beneficiaries, according to HHS Secretary Alex Azar, who spoke about the impact of social determinants of health during a speech with the Hatch Foundation for Civility and Solutions on Nov. 14.

CMS sent state Medicaid directors an email on Nov. 13 announcing new opportunities to design service delivery systems for treating mental health. The announcement eases previous prohibitions against using Medicaid funding to pay for short-term residential treatment in an institution for mental disease.

FDA Commissioner Scott Gottlieb, MD, has signaled that the agency will strengthen its expanded access (EA) program to enable more patients to access investigational medical products and treatments for serious or life-threatening diseases.

CMS proposed regulatory reform of the Medicaid managed care program on Nov. 8, giving states more freedom over network-adequacy standards.

After holding control of Congress for eight years and attempting to eradicate the Affordable Care Act dozens of times, Republicans lost the majority in the House on Nov. 6 during the midterm elections. The partisan shakeup could have several impacts on the nation's healthcare agenda.

CMS plans to cut $380 million in 2019 by establishing site-neutral payments to hospitals. The change, which was outlined in CMS’ Outpatient Prospective Payment System final rule on Friday, will lower out-of-pocket costs for beneficiaries but also reduce payments for hospital-owned outpatient settings.

CMS finalized the Physician Fee Schedule and Quality Payment Program, delaying a controversial coding change that would have resulted in a payment cut for doctors.

The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

A large chunk of the American population doesn’t know when the open enrollment period is to purchase healthcare insurance, according to a recent study by insuranceQuotes. And recent political moves have contributed to confusion among Americans.

Industry groups and healthcare experts disagree on various parts of President Trump's new plan to lower Medicare Part B drug prices, which was announced last week.

The FDA approved a new flu medicine that could shorten the time people are sick—and it can be taken in one dose.

More than 25 patient and consumer groups have spoken out against a new guidance issued by CMS on Tuesday that allows states to skirt patient protections mandated under the Affordable Care Act.